These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3146502)

  • 21. Investigation of human growth hormone releasing factor in adults.
    Sassolas G; Biot-Laporte S; Cohen R; Chatelain P; Boissel JP; Dupin P; Garry P; Claustrat B; Girard P; Borson F
    Horm Res; 1986; 24(2-3):99-111. PubMed ID: 3093356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose response of two synthetic human growth hormone-releasing factors on growth hormone release in heifers and pigs.
    Peticlerc D; Pelletier G; Lapierre H; Gaudreau P; Couture Y; Dubreuil P; Morisset J; Brazeau P
    J Anim Sci; 1987 Oct; 65(4):996-1005. PubMed ID: 2889716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma growth hormone, insulin-like growth factor-I, and milk production responses to exogenous human growth hormone-releasing factor analogs in dairy cows.
    Hodate K; Johke T; Ozawa A; Ohashi S
    Endocrinol Jpn; 1990 Apr; 37(2):261-73. PubMed ID: 2226345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute intravenous growth hormone-releasing factor on plasma prolactin in short children and patients with growth hormone deficiency.
    Chatelain PG; Sassolas G; Catbeh N; Bio-Laporte S; Ferry S; Claustrat B; David M; François R
    Horm Res; 1985; 22(1-2):46-51. PubMed ID: 3928476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma growth hormone (GH) response to GH-releasing factor (SM-8144) in children of short stature and patients with GH deficiency.
    Takano K; Shizume K; Imura H; Irie M; Kumahara Y; Shimizu N
    Endocrinol Jpn; 1987 Feb; 34(1):117-28. PubMed ID: 3111840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Growth hormone-releasing factor (GRF) in the treatment of the child with a growth hormone (GH) deficiency].
    Lanes R
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():169-71. PubMed ID: 1636959
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K; Hizuka N; Shizume K; Honda N; Ling NC
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of human growth hormone-releasing factor and a potent analog on antibody formation in African green monkeys.
    Mowles TF; Stricker P; Felix AM; Soike KF; Campbell RM
    Horm Metab Res; 1991 Nov; 23(11):530-4. PubMed ID: 1816063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma somatotropin response to exogenous growth hormone releasing factor in lambs.
    Kensinger RS; McMunn LM; Stover RK; Schricker BR; Maccecchini ML; Harpster HW; Kavanaugh JF
    J Anim Sci; 1987 Apr; 64(4):1002-9. PubMed ID: 3106295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
    Thorner MO; Rogol AD; Blizzard RM; Klingensmith GJ; Najjar J; Misra R; Burr I; Chao G; Martha P; Mcdonald J
    Pediatr Res; 1988 Aug; 24(2):145-51. PubMed ID: 3141891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group.
    Lanes R; Carrillo E
    J Pediatr Endocrinol; 1994; 7(4):303-8. PubMed ID: 7735367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic administration of a new potent agonist of growth hormone- releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action.
    Kovács M; Halmos G; Groot K; Izdebski J; Schally AV
    Neuroendocrinology; 1996 Sep; 64(3):169-76. PubMed ID: 8875434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of growth hormone release to human growth hormone-releasing factor and its analogs in the bovine.
    Hodate K; Johke T; Ohashi S
    Endocrinol Jpn; 1986 Aug; 33(4):519-25. PubMed ID: 3098550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
    Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
    Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.